Premium
P3‐272: A COMPARISON OF EEG CONNECTIVITY OUTCOME MEASURES FOR ALZHEIMER'S DISEASE IN A DOUBLE‐BLINDED RANDOMIZED CLINICAL TRIAL OF PQ912
Author(s) -
Briels Casper T.,
Stam Cornelis J.,
Scheltens Philip,
Gouw Alida A.
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.1632
Subject(s) - placebo , electroencephalography , post hoc analysis , dementia , audiology , medicine , correlation , psychology , coherence (philosophical gambling strategy) , physical therapy , physical medicine and rehabilitation , neuroscience , disease , statistics , mathematics , pathology , alternative medicine , geometry
Model 1: Sex, country and ApoE as factors and age and baseline value as cova Model 2: Model 1 + change in alpha 1, alpha 2, beta, delta and theta power as matic Sprotte needles and gentle aspiration of up to 22 mL of CSF are relatively safe procedures with few side effects. The safety profile should reassure volunteers and clinicians that LPs should be considered as a reasonable option for biomarker testing in the AD research setting.